Can a phone app shield new mothers from postpartum depression?

NCT ID NCT06365645

First seen Aug 19, 2026 ยท Last updated Aug 19, 2026

Summary

This trial is testing whether a smartphone app called M.Bapp, which delivers cognitive behavioral therapy, is a feasible and acceptable way to prevent postpartum depression in mothers at high risk. The study will enroll pregnant women who are at least 32 weeks along and have no recent history of depression or anxiety. Participants will be randomly assigned to use M.Bapp or a standard parenting education app, and researchers will measure how many women use the app and how satisfied they are with it.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
M.Bapp, a smartphone app delivering cognitive behavioral therapy content
What this could lead to
If effective, this app could offer a scalable, accessible way to prevent postpartum depression in at-risk mothers, potentially reducing the burden of this condition.
What could go wrong
This is an early feasibility study with a small sample, so it may not prove the app's effectiveness. The app's success depends on user engagement and satisfaction, which may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTPARTUM ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Women & Infants Hospital of Rhode Island

    Providence, Rhode Island, 02905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.